Collaboration - December 11, 2013
Lundbeck and Otsuka to develop investigational vaccine candidate
H. Lundbeck and Otsuka Pharmaceutical today announced that they will further expand their collaboration to include the development of Lu AF20513, an investigational vaccine candidate for Alzheimer’s disease. Lu AF20513 is an anti-Aβ active vaccine candidate for Alzheimer’s disease which currently is in preclinical development. It is designed towards an optimal immunogenic response in the elderly, […]
Collaboration - December 6, 2013
Genmab announces expansion with Janssen Biotech
Genmab have announced an expansion of its collaboration with Janssen Biotech to create and develop bispecific antibodies using the DuoBody technology platform. The original agreement entitled Janssen to work on up to ten DuoBody programs. Under the terms of the amendment, Janssen is entitled to work on up to ten additional programs. Genmab will receive […]
Collaboration - November 28, 2013
New European collaboration on vaccine
Several leading organizations are joining forces to launch a project to improve benefit and risk assesments of vaccines. The project will pave way for a pan-European framework for rapidly assessing and communicating the benefits and risks of vaccines. The hope is that the framework could make it easier for regulators and public health authorities to […]
Collaboration - November 14, 2013
MVA-project will link Swedish-Danish health data
Medicon Valley Alliance (MVA) has received 200.000 euro for a new project that will investigate how to combine Danish and Swedish data sources and health registries. The project, which is financed by the EU Interreg Programme, Region Skåne and the Capital Region of Denmark, will focus on data related to breast cancer. In order to […]
Collaboration - November 13, 2013
Vitrolife and Biolamina increase collaboration
The companies have decided to increase their collaboration and, as part of this greater collaboration, Vitrolife has invested in Biolamina together with the company’s present owners. Vitrolife has collaborated with the Stockholm-based Biolamina within the stem-cell field since 2012. During spring the collaboration resulted in the launch of a new freeze medium for stem cells, […]
Collaboration - November 8, 2013
Nuevolution in multi-target collaboration deal
The Denmark-based drug discovery company Nuevolution A/S has signed a collaboration deal with Cancer Research Technology to discover anti-cancer drug molecules. The collaboration aims to identify drug leads that block the activity of a number of cancer therapeutic targets. Through the partnership drug candidate molecules which home in on selected targets will be identified by […]
